Synergy CHC Corp. Cost of Revenue
Synergy CHC Corp. (SNYR) reported Cost of Revenue of $11.19 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2025-03-31
- Synergy CHC Corp. cost of goods and services sold for the quarter ending 2024-12-31 was $3.77M, a 60.69% increase year-over-year.
- Synergy CHC Corp. cost of goods and services sold for the quarter ending 2024-09-30 was $2.34M, a 22.86% decline year-over-year.
- Synergy CHC Corp. cost of goods and services sold for the quarter ending 2023-12-31 was $2.35M.
- Synergy CHC Corp. cost of goods and services sold for the quarter ending 2023-09-30 was $3.03M.
- Synergy CHC Corp. cost of goods and services sold for fiscal 2024 was $11.19M, a 4.62% increase from fiscal 2023.
- Synergy CHC Corp. cost of goods and services sold for fiscal 2023 was $10.70M.
- Synergy CHC Corp. cost of goods and services sold for fiscal 2019 was $9.14M, a 17.21% decline from fiscal 2018.
- Synergy CHC Corp. cost of goods and services sold for fiscal 2018 was $11.04M, a 12.41% increase from fiscal 2017.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $6.11M derived: sum of 2 quarters · filed 2025-03-31 | $11.19M 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $2.34M 10-Q · filed 2024-12-06 | $7.42M 10-Q · filed 2024-12-06 | |||
| 2023-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.37M derived: sum of 2 quarters · filed 2025-03-31 | $10.70M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $3.03M 10-Q · filed 2024-12-06 | $8.35M 10-Q · filed 2024-12-06 | |||
| 2020-03-31 | $1.50M 10-Q · filed 2020-06-29 | $4.00M derived: sum of 2 quarters · filed 2020-06-29 | $6.49M derived: sum of 3 quarters · filed 2020-06-29 | $8.09M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $4.99M derived: sum of 2 quarters · filed 2020-04-29 | $6.60M derived: sum of 3 quarters · filed 2020-04-29 | $9.14M 10-K · filed 2020-04-29 | |
| 2019-09-30 | $2.49M 10-Q · filed 2019-11-14 | $4.10M derived: sum of 2 quarters · filed 2019-11-14 | $6.64M 10-Q · filed 2019-11-14 | $9.18M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-06-30 | $1.61M 10-Q · filed 2019-08-13 | $4.15M 10-Q · filed 2019-08-13 | $6.68M derived: sum of 3 quarters · filed 2020-06-29 | $9.63M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2019-03-31 | $2.54M 10-Q · filed 2020-06-29 | $5.08M derived: sum of 2 quarters · filed 2020-06-29 | $8.02M derived: sum of 3 quarters · filed 2020-06-29 | $10.77M derived: sum of 4 quarters · filed 2020-06-29 | |
| 2018-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $5.48M derived: sum of 2 quarters · filed 2020-04-29 | $8.23M derived: sum of 3 quarters · filed 2020-04-29 | $11.04M 10-K · filed 2020-04-29 | $12.47M 10-K · filed 2019-03-29 |
| 2018-09-30 | $2.95M 10-Q · filed 2019-11-14 | $5.69M derived: sum of 2 quarters · filed 2019-11-14 | $8.50M 10-Q · filed 2019-11-14 | $10.70M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $2.74M 10-Q · filed 2019-08-13 | $5.55M 10-Q · filed 2019-08-13 | $7.75M derived: sum of 3 quarters · filed 2019-08-13 | $10.41M derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $2.81M 10-Q · filed 2019-05-03 | $5.01M derived: sum of 2 quarters · filed 2019-05-03 | $7.66M derived: sum of 3 quarters · filed 2019-05-03 | $10.13M derived: sum of 4 quarters · filed 2019-05-03 | |
| 2017-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $4.85M derived: sum of 2 quarters · filed 2019-03-29 | $7.32M derived: sum of 3 quarters · filed 2019-03-29 | $9.82M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $2.66M 10-Q · filed 2018-11-13 | $5.12M derived: sum of 2 quarters · filed 2018-11-13 | $7.62M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $2.46M 10-Q · filed 2018-08-14 | $4.96M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |